SCHEMBL16057208

SCHEMBL16057208

CCCCc1c(-c2c(C)cccc2C)ccn(C(=O)O)c1=O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SLC37A4 O43826 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ MYC P01106 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CXCR5 P32302 1/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ DCTPP1 Q9H773 1/20 0.34
▸ OXER1 Q8TDS5 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA2 P47869 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ PABPC1 P11940 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16057538 0.87 MAPT (0.40) SLC37A4MAPTKDM4EALDH1A1LMNA
SCHEMBL14977502 0.80 GCGR (0.41) MAPTKDM4EALDH1A1LMNADCTPP1
SCHEMBL16056988 0.78 RARB (0.40) ALDH1A1HPGD
SCHEMBL16057557 0.78 CYP3A4 (0.47) KDM4EALDH1A1MEN1KMT2A
SCHEMBL16057532 0.78 MAPT (0.39) MAPT
SCHEMBL16057331 0.76 DCTPP1 (0.43) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL16058817 0.75 PSEN1 (0.37) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL16056895 0.71 RARB (0.48) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL16057210 0.69 CYSLTR2 (0.38) MAPTCXCR5OXER1
SCHEMBL16057311 0.68 NPC1 (0.34) MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828338-B2 Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-28 — — US disclosed
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-10 — — US disclosed
WO-2014144836-A2 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS NAAA, FAAH, FAAH2 SLC37A4 4344/4885MAPT 929/4885MYC 2157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback